Y. Shen et al., “Bioactive Constituents from Haliclona sp., a Formosan Marine Sponge,” The Chinese Pharmaceutical Journal, 1996, 48, pp. 1-10. |
J. Allen et al., “The Simple β-Carboline Alkaloids,” Phytochemistry, 1980, vol. 19, pp. 1573-1582. |
G. Pimpinella et al., “Interaction of β-carbolines with central dopaminergic transmission in mice: structure-activity relationships,” Neuroscience Letters 189 (1995), pp. 121-124. |
B. Wiczynska et al., “Antidepressant profile of 9-methyl-2[-3-(4-phenyl-1-piperazinylpropyl)]-1,2,3,4-tetrahydro-beta-carbolin-1-one (B-193),” Pol J. Pharmacol Pharm Jul.-Aug. 1989; 41(4):331-44; 1 page. |
G. Dorey et al., “Synthetic Routes to 4-Amino-3-carboxy-β-carboline Derivatives: Incidental Formation of Novel Furo[3,4-c]-β-carbolin-2-ones Displaying High Affinities for the Benzodiazepine Receptor,” J. Med. Chem. 1995, 38, pp. 189-198. |
L. Larsen et al., “β-Carbolines from the Blue-Green Alga Dichothrix Baueriana,” Journal of Natural Products, vol. 57, No. 3, pp. 419-421, Mar. 1994. |
T. Kurihara et al., “Meisenheimer Rearrangement of Azetopyridoindoles. VIII.1) Synthesis and Antiviral Activities of 12-Carbaeudistomin Analogs,” Chem. Pharm. Bull. 44(5) pp. 900-908 (1996). |
S. Adesanya et al., “Brominated β-Carbolines from the Marine Tunicate Eudistoma Album,” Journal of Natural Products, vol. 55, No. 4, pp. 525-527, Apr. 1992. |
B. Lee et al., “Suppression of inducible nitric oxide synthase expression in RAW 264.7 macrophages by two β-carboline alkaloids extracted from Melia azedarach,” European Journal of Pharmacology 406 (2000) pp. 301-309. |
K. Narasimha Rao et al.; “Thymidylate Synthase Activity and the Cell Growth Are Inhibited by the β-Carboline-Benzoquinolizidine Alkaloid Deoxytubulosine,” J. Biochem Molecular Toxicology, vol. 12, No. 3, 1998, pp. 167-173. |
J. Osiadacz et al., “Sequence-Selectivity of 5,11-Dimethyl-5H-indolo[2,3-b]quinoline Binding to DNA. Footprinting and Molecular Modeling Studies,” Bioorganic & Medicinal Chemistry 8 (2000), pp. 937-943. |
S. Mahboobi et al., “beta-Carbolinedione derivatives as topoisomerase I inhibitors,” Arch Pharm (Weinheim) Jul. 1999; 332(7):249-54; 1 page. |
F. Pognan et al., “A Carboline Derivative as a Novel Mammalian DNA Topoisomerase II Targeting Agent,” Biochemical Pharmacology, vol. 44, No. 11, pp. 2149-2155, 1992. |
P. Fossé et al., “Stimulation by γ-Carboline Derivatives (Simplified Analogues of Antitumor Ellipticines) of Site Specific DNA Cleavage by Calf DNA Topoisomerase II,” Biochemical Pharmacology, vol. 39, No. 4, pp. 669-676, 1990. |
W. Peczyńska-Czoch et al., “Synthesis and Structure—Activity Relationship of Methyl-Substituted Indolo[2,3-b]quinolines: Novel Cytotoxic, DNA Topoisomerase II Inhibitors,” J. Med. Chem. 1994, 37, pp. 3503-3510. |
Y. Funayama et al., “Effects of β- and γ-carboline derivatives on DNA topoisomerase activities,” Mutation Research 349 (1996), pp. 183-191. |
F. Denizot et al., “Rapid colorimetric assay for cell growth and survival: Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability,” Journal of Immunological Methods, 89 (1986), pp. 271-277. |